Cardiovascular effects of mexiletine for treatment of myotonia in myotonic dystrophy type 1

Rev Esp Cardiol (Engl Ed). 2021 Nov;74(11):986-987. doi: 10.1016/j.rec.2021.04.016. Epub 2021 Jun 11.
[Article in English, Spanish]
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Humans
  • Mexiletine / therapeutic use
  • Myotonia* / diagnosis
  • Myotonia* / drug therapy
  • Myotonic Dystrophy* / complications
  • Myotonic Dystrophy* / drug therapy

Substances

  • Mexiletine